190 related articles for article (PubMed ID: 32808927)
1. TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex.
Zimmerli D; Borrelli C; Jauregi-Miguel A; Söderholm S; Brütsch S; Doumpas N; Reichmuth J; Murphy-Seiler F; Aguet M; Basler K; Moor AE; Cantù C
Elife; 2020 Aug; 9():. PubMed ID: 32808927
[TBL] [Abstract][Full Text] [Related]
2. Mutations in
Cantù C; Felker A; Zimmerli D; Prummel KD; Cabello EM; Chiavacci E; Méndez-Acevedo KM; Kirchgeorg L; Burger S; Ripoll J; Valenta T; Hausmann G; Vilain N; Aguet M; Burger A; Panáková D; Basler K; Mosimann C
Genes Dev; 2018 Nov; 32(21-22):1443-1458. PubMed ID: 30366904
[TBL] [Abstract][Full Text] [Related]
3. A cytoplasmic role of Wnt/β-catenin transcriptional cofactors Bcl9, Bcl9l, and Pygopus in tooth enamel formation.
Cantù C; Pagella P; Shajiei TD; Zimmerli D; Valenta T; Hausmann G; Basler K; Mitsiadis TA
Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174279
[TBL] [Abstract][Full Text] [Related]
4. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
5. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
de la Roche M; Worm J; Bienz M
BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
[TBL] [Abstract][Full Text] [Related]
6. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
[TBL] [Abstract][Full Text] [Related]
7. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of Pygo in organ development dependent and independent Wnt signalling.
Shi Y; Wu X; Zhu S; Huang H; Zhuang J; Yuan H; Yuan W; Zhu P
Biochem Soc Trans; 2020 Aug; 48(4):1781-1794. PubMed ID: 32677664
[TBL] [Abstract][Full Text] [Related]
9. Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9.
van Tienen LM; Mieszczanek J; Fiedler M; Rutherford TJ; Bienz M
Elife; 2017 Mar; 6():. PubMed ID: 28296634
[TBL] [Abstract][Full Text] [Related]
10. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
[TBL] [Abstract][Full Text] [Related]
11. SOX7 Suppresses Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction.
Fan R; He H; Yao W; Zhu Y; Zhou X; Gui M; Lu J; Xi H; Deng Z; Fan M
DNA Cell Biol; 2018 Feb; 37(2):126-132. PubMed ID: 29271667
[TBL] [Abstract][Full Text] [Related]
12. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
13. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
[TBL] [Abstract][Full Text] [Related]
14. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
[TBL] [Abstract][Full Text] [Related]
15. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
Hoffmans R; Basler K
Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
[TBL] [Abstract][Full Text] [Related]
16. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
17. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
18. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
19. Interactions between FGF and Wnt signals and Tbx3 gene expression in mammary gland initiation in mouse embryos.
Eblaghie MC; Song SJ; Kim JY; Akita K; Tickle C; Jung HS
J Anat; 2004 Jul; 205(1):1-13. PubMed ID: 15255957
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a beta-catenin/BCL9/Tcf4 complex.
Sampietro J; Dahlberg CL; Cho US; Hinds TR; Kimelman D; Xu W
Mol Cell; 2006 Oct; 24(2):293-300. PubMed ID: 17052462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]